se of virgin coconut oil in the treatment of Alzheimer's dementia

Evaluation of the Efficacy of Agomelatine as Add-on Therapy on the Aggression, Agitation, and its Relationship with Serum Brain-Derived Neurotrophic Factor (BDNF) of Patients with Alzheimer’s disease Dementia

计划入组 56 人

Evaluation of the Uganda Adopted version of the WHO-iSupport intervention for caregivers of persons with Alzheimer's disease and related Dementias (ADRD)

计划入组 119 人

dementia vaccine

Frontotemporal dementia (TSOI)

SRXXX (Senile dementia)

The Bluefield Project To Cure Frontotemporal Dementia

United States

SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT

Australia

ProMIS Neurosciences

Canada

BioXcel Therapeutics Advances Phase 3 Trials of BXCL501 for Agitation

Alpha Cognition's ZUNVEYL Receives FDA Approval for Alzheimer's Treatment, Set for Q1 2025 Launch

FDA Approves Zunveyl (benzgalantamine) for Mild-to-Moderate Alzheimer's Disease